Long noncoding RNA (lncRNA) plays a crucial role in many critical biological processes and participates in complex human diseases through interaction with proteins. Considering that identifying lncRNA–protein interactions through experimental methods is expensive and time-consuming, we propose a novel method based on deep learning that combines raw sequence composition features, hand-designed features and structure features, called LGFC-CNN, to predict lncRNA–protein interactions. The two sequence preprocessing methods and CNN modules (GloCNN and LocCNN) are utilized to extract the raw sequence global and local features. Meanwhile, we select hand-designed features by comparing the predictive effect of different lncRNA and protein features combinations. Furthermore, we obtain the structure features and unifying the dimensions through Fourier transform. In the end, the four types of features are integrated to comprehensively predict the lncRNA–protein interactions. Compared with other state-of-the-art methods on three lncRNA–protein interaction datasets, LGFC-CNN achieves the best performance with an accuracy of 94.14%, on RPI21850; an accuracy of 92.94%, on RPI7317; and an accuracy of 98.19% on RPI1847. The results show that our LGFC-CNN can effectively predict the lncRNA–protein interactions by combining raw sequence composition features, hand-designed features and structure features.
Spatial transcriptomics technologies have enabled comprehensive measurements of gene expression profiles while retaining spatial information and matched pathology images. However, noise resulting from low RNA capture efficiency and experimental steps needed to keep spatial information may corrupt the biological signals and obstruct analyses. Here, we develop a latent diffusion model DiffuST to denoise spatial transcriptomics. DiffuST employs a graph autoencoder and a pre-trained model to extract different scale features from spatial information and pathology images. Then, a latent diffusion model is leveraged to map different scales of features to the same space for denoising. The evaluation based on various spatial transcriptomics datasets showed the superiority of DiffuST over existing denoising methods. Furthermore, the results demonstrated that DiffuST can enhance downstream analysis of spatial transcriptomics and yield significant biological insights.
Spindle neurons (SPNs), also known as von Economo neurons (VENs), are predominantly found in large-brained species including humans. SPNs in human neocortex are implicated in cognitive functions and affected in various brain disorders. Despite their unique morphology, whether SPNs possess distinctive electrophysiological properties and transcriptomic identities remains unclear. Here, we performed whole-cell patch clamp recording (134 cells) together with RNA-sequencing (patch-seq, 124 cells) on visually identified SPNs and pyramidal cells (PCs) in human cortical slices. Compared with putative extratelencephalic-projecting PCs, SPNs possess less complex proximal apical dendrites and emanate axons from the basal dendritic trunk. Additionally, they exhibit heightened excitability and characteristic firing properties, including robust bursting and persistent firing pattern. Patch-seq analysis revealed transcriptomic heterogeneity within SPNs, and identified their fingerprint genes. Collectively, our results indicate that SPNs form a molecularly and functionally distinctive neuronal population, which may serve as a specialized neural substrate for human cortical processing.
5 May 2026 in IEEE Transactions on Computational Biology and Bioinformatics
Spatial transcriptomics technologies have enabled comprehensive measurements of gene expression profiles while retaining spatial information, with most platforms also providing matched pathology images. However, noise resulting from low RNA capture efficiency and experimental steps needed to keep spatial information may corrupt the biological signals and obstruct analyses. Here, we develop a latent diffusion model DiffuST to denoise spatial transcriptomics. DiffuST employs a graph autoencoder and a pre-trained model to extract different-scale features from spatial information and pathology images. Then, a latent diffusion model is leveraged to map different scales of features to the same space for denoising. The evaluation based on various spatial transcriptomics datasets showed the superiority of DiffuST over existing denoising methods. Furthermore, the results demonstrated that DiffuST can enhance downstream analysis of spatial transcriptomics and yield significant biological insights.
Spatial transcriptomics reveals cellular heterogeneity, intercellular communication, and tissue organization, but its cost and limited accessibility restrict clinical use. Here, we present VISTA, a model that integrates multi-scale histological features and spatial context to infer spatial gene expression from H&E-stained tissue images. Across leave-one-section-out cross-validation and independent validation, VISTA robustly predicted thousands of genes and outperformed state-of-the-art methods. Beyond expression reconstruction, VISTA enabled clinically relevant downstream analyses. In TCGA breast cancer samples, it identified survival-associated genes, stratified prognostic risk groups, and revealed adverse tumor-associated spatial subtypes. In our in-house intrahepatic cholangiocarcinoma cohort, it preserved tumor–normal organization and identified CLDN4 and CYP3A4 as complementary spatial biomarkers. In HER2+ breast cancer, it predicted pathological response to neoadjuvant trastuzumab-based therapy and linked response-associated regions to immune and cytokine-related programs. These results support virtual spatial transcriptomics from routine histopathology for oncology applications.
Adeno-associated virus (AAV) capsids have shown great promise as delivery vectors for gene therapy. However, the natural properties of AAV capsids impose significant limitations on their efficacy. While capsid library screening and directed evolution have facilitated the development of improved vectors, current methods for generating AAV libraries frequently yield nonviable variants that fail to assemble or package DNA. Here, we propose a viability-guided diffusion model AAVDiffusion for de novo viable AAV capsid design. AAVDiffusion iteratively denoises Gaussian vectors into vectors of AAV capsid protein sequences, yielding intermediate latent variables. By leveraging the continuous nature of these latent variables, AAVDiffusion integrates an additional viability classifier that applies gradient updates to enhance the generation of viable AAV sequences. Through extensive computational tests, AAVDiffusion exhibits superior performance in generating viable AAV sequences. Furthermore, 196 AAV candidates were identified through a selection workflow, with the potential to cross the blood-brain barrier, thereby offering safer and more effective gene therapies for brain diseases. AAVDiffusion offers a powerful and efficient computational method for designing viable AAV capsids, advancing the development of AAV vectors for gene therapy.